Practical Recommendations for Therapeutic Drug Monitoring of Kinase Inhibitors in Oncology.

MLA

Verheijen, Remy B., et al. “Practical Recommendations for Therapeutic Drug Monitoring of Kinase Inhibitors in Oncology.” Clinical Pharmacology and Therapeutics, vol. 102, no. 5, Nov. 2017, pp. 765–76. EBSCOhost, https://doi.org/10.1002/cpt.787.

APA

Verheijen, R. B., Yu, H., Schellens, J. H. M., Beijnen, J. H., Steeghs, N., & Huitema, A. D. R. (2017). Practical Recommendations for Therapeutic Drug Monitoring of Kinase Inhibitors in Oncology. Clinical Pharmacology and Therapeutics, 102(5), 765–776. https://doi.org/10.1002/cpt.787

Chicago

Verheijen, Remy B, Huixin Yu, Jan H M Schellens, Jos H Beijnen, Neeltje Steeghs, and Alwin D R Huitema. 2017. “Practical Recommendations for Therapeutic Drug Monitoring of Kinase Inhibitors in Oncology.” Clinical Pharmacology and Therapeutics 102 (5): 765–76. doi:10.1002/cpt.787.